Wednesday, 7 October 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Transgene Biotek Ltd

NSE: TRABI · BSE: 526139 · Healthcare · 14 announcements

Share price: ₹2.37
Market cap: ₹17.96 Cr
Revenue (annual): ₹0.21 Cr
Net profit (annual): ₹-1.65 Cr
P/E (TTM): -11.2×Sector 53.1×
Promoter holding: 23.64%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Management Change 2 Fund Raise 1 Debt & Borrowing 1 Capital Structure Change 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

7 Aug 2026 11:43 IST BSE

Financial Results

Transgene Biotek Q1 FY27 Results: Net Loss of ₹0.4 Cr, Loss Widens

Transgene Biotek Ltd reported revenue from operations of ₹0.1 Cr and a net loss of ₹0.4 Cr for Q1 FY27.

Key figure: Net loss ₹0.4 Cr

Open full results → Read the filing ↗

29 May 2026 11:36 IST BSE

Financial Results

Transgene Biotek Q4 FY26 Results: Net Loss of ₹0.5 Cr, Loss Narrows

Transgene Biotek Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and a net loss of ₹0.5 Cr for Q4 FY26.

Key figure: Net loss ₹0.5 Cr

Open full results → Read the filing ↗

29 May 2026 11:35 IST BSE

Financial Results

Transgene Biotek Financial Results

Transgene Biotek Ltd reported audited financial results for the year ended March 31, 2026. The company recorded a standalone net loss of ₹1.65 Crore for FY26.

Read the filing ↗